Genotype-guided dosing algorithm

OTHER3 trials

Sponsors

Utrecht Institute for Pharmaceutical Sciences

Conditions

Atrial FibrillationAtrial Fibrillation (AF)Venous ThromboembolismVenous Thromboembolism (VTE)

Phase 4

EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon

CompletedNCT01119274

Utrecht Institute for Pharmaceutical SciencesAtrial Fibrillation (AF), Venous Thromboembolism (VTE)

Start: 2010-11-30End: 2013-04-30Target: 970Updated: 2013-06-18

EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol

CompletedNCT01119261

Utrecht Institute for Pharmaceutical SciencesAtrial Fibrillation, Venous Thromboembolism

Start: 2010-11-30End: 2013-06-30Target: 970Updated: 2013-06-18

EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin

CompletedNCT01119300

Utrecht Institute for Pharmaceutical SciencesAtrial Fibrillation, Venous Thromboembolism

Start: 2011-01-31End: 2013-10-31Updated: 2014-12-03

Related Papers

A Randomized Trial of Genotype-Guided Dosing of Warfarin

New England Journal of Medicine2013-11-19803 citations

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon

New England Journal of Medicine2013-11-19226 citations